Efficacy and Safety of Brinzolamide/Brimonidine Fixed Combination BID Compared to Brinzolamide BID Plus Brimonidine BID in Subjects With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)

NCT02339584 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

493

Enrollment

INDUSTRY

Sponsor class

Conditions

Open-Angle Glaucoma
Ocular Hypertension

Interventions

DRUG: Brinzolamide 10 mg/mL / Brimonidine 2 mg/mL fixed combination eye drops, suspension
DRUG: Brinzolamide 10 mg/mL eye drops, suspension
DRUG: Brimonidine 2 mg/mL eye drops, solution
DRUG: Vehicle

Sponsor

Alcon Research